Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Companies cannot compete on labor costs in the US. According to the Reshoring Institute, if labor constitutes more than 50% of a product's build cost, it is not a candidate for US reshoring. Success hinges on automating production to extract labor, making high-capital sectors like pharma more suitable.

Related Insights

The reshoring trend isn't about replicating traditional manufacturing. Instead, the U.S. gains a competitive advantage by leveraging automation and robotics, effectively trading labor costs for electricity costs. This strategy directly challenges global regions that rely on exporting cheap human labor.

Bringing manufacturing back to the US won't mean a return of old assembly line jobs. The real opportunity is to leapfrog to automated factories that produce sophisticated, tech-infused products. This creates a new class of higher-skill, higher-pay "blue collar plus" jobs focused on building and maintaining these advanced manufacturing systems.

To find the leading edge of US reshoring, look beyond traditional industrial firms. Major technology companies like the "Mag7" are now aggressively hiring top-tier physical AI, robotics, and manufacturing talent. This signals a fundamental shift in where the most significant capital and innovation in US manufacturing are being directed.

The idea that the US is intrinsically uncompetitive in certain manufacturing areas like consumer electronics is 'crap.' Automation allows high-wage countries to compete. Ceding entire sectors is a strategic error; the US has every advantage needed to compete if it chooses to.

Despite tariffs making imports more expensive, moving furniture production back to the US is seen as unrealistic. The primary obstacle is not financial, but a critical shortage of trained workers who can and want to do the work, a deficit that tariffs cannot fix.

To compete with China in manufacturing, the US can't rely on labor volume but on productivity from AI and robotics. This requires eliminating the friction of distance between R&D talent (in the Bay Area) and factory floors, making talent-proximate manufacturing parks a strategic necessity.

The belief that China's manufacturing advantage is cheap labor is dangerously outdated. Its true dominance lies in a 20-year head start on manufacturing autonomy, with production for complex products like the PlayStation 5 being 90% automated. The US outsourced innovation instead of automating domestically.

The playbook of leveraging a large, low-cost workforce to become a manufacturing power is obsolete. Future competitiveness will be determined by automation density (robots per 100,000 people), making it impossible for nations like India to simply replicate China's industrial rise.

The ongoing wave of investment in automation and upgrading existing US facilities is not the end goal. It's the first step for companies recalculating supply chain costs due to tariffs. This "brownfield" optimization proves the economic viability of US production, paving the way for larger "greenfield" projects once existing capacity is maximized.

Contrary to political rhetoric, Siemens' CEO provides a ground-level view that a widespread return of manufacturing to the US has not yet materialized. He cites labor shortages and policy uncertainty as key drags, despite real investments in specific sectors like pharma and semiconductors.